Syndrome of inappropriate antidiuretic hormone overview: Difference between revisions
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The '''syndrome of inappropriate antidiuretic hormone''' (SIADH) is a condition commonly found in individuals hospitalized for [[central nervous system]] (CNS) injury. SIADH is a syndrome characterized by excessive release of [[Vasopressin|antidiuretic hormone]] (ADH or [[vasopressin]]) from the [[posterior pituitary]] gland or any other source, resulting in [[hyponatremia]], and sometimes fluid overload. Syndrome of inappropriate antidiuretic hormone production (SIADH) leads to excessive water retention and thus a decrease in [[sodium]] concentration. SIADH may be occur as a result of central nervous system diseases, [[cancer]]s, [[pulmonary disease]]s and some drugs. Signs and symptoms of SIADH vary widely. Some patients with SIADH may become severely ill while others may have no symptoms at all. Common symptoms include [[nausea]], [[vomiting]], [[loss of appetite]], [[fatigue]], [[weakness]] | The '''syndrome of inappropriate antidiuretic hormone''' (SIADH) is a condition commonly found in individuals hospitalized for [[central nervous system]] (CNS) injury. SIADH is a syndrome characterized by excessive release of [[Vasopressin|antidiuretic hormone]] (ADH or [[vasopressin]]) from the [[posterior pituitary]] gland or any other source, resulting in [[hyponatremia]], and sometimes fluid overload. Syndrome of inappropriate antidiuretic hormone production (SIADH) leads to excessive water retention and thus a decrease in [[sodium]] concentration. SIADH may be occur as a result of central nervous system diseases, [[cancer]]s, [[pulmonary disease]]s and some drugs. Signs and symptoms of SIADH vary widely. Some patients with SIADH may become severely ill while others may have no symptoms at all. Common symptoms include [[nausea]], [[vomiting]], [[loss of appetite]], [[fatigue]], [[weakness]] and altered [[consciousness]]. Blood tests of [[hyponatremia]] ([[sodium]] <135 mEq/L) and low serum [[osmolality]] (<280 mOsm/kg) may prompt the diagnosis of SIADH. Treatment of SIADH depends on the cause. Restriction of water intake and supplementation of sodium may lead to improvement. Prognosis of SIADH varies depending on the cause. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Syndrome of SIADH was initially described by Leaf and Mambi in the year 1951.Later it was described by researchers from Boston, Massachusetts and Bethesda, Maryland (including Dr Frederic Bartter) in two patients with lung cancer in the year 1957.The condition is occasionally referred to as Schwartz-Bartter syndrome. | Syndrome of SIADH was initially described by Leaf and Mambi in the year 1951. Later it was described by researchers from Boston, Massachusetts and Bethesda, Maryland (including Dr Frederic Bartter) in two patients with lung cancer in the year 1957.The condition is occasionally referred to as Schwartz-Bartter syndrome. | ||
==Classification== | ==Classification== | ||
| Line 52: | Line 52: | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
Lab findings helpful in diagnosing [[SIADH]], include serum [[electrolytes]],especially[[ sodium]],[[BUN]],[[creatinine]], [[glucose]] levels, and [[osmolality]]. Patients with[[ syndrome of inappropriate antidiuretic hormone]] may be characterised with [[hyponatremia]] ([[sodium]] <135 mEq/L) and low serum [[osmolality]] (<280 mOsm/kg). Patients with syndrome of inappropriate antidiuretic hormone show elevated urinary [[sodium]] level (>20 mmol/L) and urine [[osmolality ]](generally >100 mOsm/L). They also have low | Lab findings helpful in diagnosing [[SIADH]], include serum [[electrolytes]],especially[[ sodium]],[[BUN]],[[creatinine]], [[glucose]] levels, and [[osmolality]]. Patients with[[ syndrome of inappropriate antidiuretic hormone]] may be characterised with [[hyponatremia]] ([[sodium]] <135 mEq/L) and low serum [[osmolality]] (<280 mOsm/kg). Patients with syndrome of inappropriate antidiuretic hormone show elevated urinary [[sodium]] level (>20 mmol/L) and urine [[osmolality ]] (generally >100 mOsm/L). They also have low | ||
[[BUN]], normal [[creatinine]],low [[uric acid]] and low [[albumin]]. | [[BUN]], normal [[creatinine]],low [[uric acid]] and low [[albumin]]. | ||
Revision as of 16:15, 24 August 2017
|
Syndrome of inappropriate antidiuretic hormone Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Syndrome of inappropriate antidiuretic hormone overview On the Web |
|
American Roentgen Ray Society Images of Syndrome of inappropriate antidiuretic hormone overview |
|
FDA on Syndrome of inappropriate antidiuretic hormone overview |
|
CDC on Syndrome of inappropriate antidiuretic hormone overview |
|
Syndrome of inappropriate antidiuretic hormone overview in the news |
|
Blogs on Syndrome of inappropriate antidiuretic hormone overview |
|
Directions to Hospitals Treating Syndrome of inappropriate antidiuretic hormone |
|
Risk calculators and risk factors for Syndrome of inappropriate antidiuretic hormone overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
The syndrome of inappropriate antidiuretic hormone (SIADH) is a condition commonly found in individuals hospitalized for central nervous system (CNS) injury. SIADH is a syndrome characterized by excessive release of antidiuretic hormone (ADH or vasopressin) from the posterior pituitary gland or any other source, resulting in hyponatremia, and sometimes fluid overload. Syndrome of inappropriate antidiuretic hormone production (SIADH) leads to excessive water retention and thus a decrease in sodium concentration. SIADH may be occur as a result of central nervous system diseases, cancers, pulmonary diseases and some drugs. Signs and symptoms of SIADH vary widely. Some patients with SIADH may become severely ill while others may have no symptoms at all. Common symptoms include nausea, vomiting, loss of appetite, fatigue, weakness and altered consciousness. Blood tests of hyponatremia (sodium <135 mEq/L) and low serum osmolality (<280 mOsm/kg) may prompt the diagnosis of SIADH. Treatment of SIADH depends on the cause. Restriction of water intake and supplementation of sodium may lead to improvement. Prognosis of SIADH varies depending on the cause.
Historical Perspective
Syndrome of SIADH was initially described by Leaf and Mambi in the year 1951. Later it was described by researchers from Boston, Massachusetts and Bethesda, Maryland (including Dr Frederic Bartter) in two patients with lung cancer in the year 1957.The condition is occasionally referred to as Schwartz-Bartter syndrome.
Classification
Four different types of SIADH, wereclassified defined by the pattern ofAVP secretion across a range of plasma osmolalities. Type A, Type B, Type C, TypeD.
Pathophysiology
Clinical picture of SIADH may result fromgenetic disorders that result inantidiuresis. Amutation affecting the gene for therenal V2 receptor, which some investigators have named nephrogenic syndrome of inappropriate antidiuresis, has been found to causeclinically significanthyponatremia. Congenital nephrogenic diabetes insipidus is characterized by a resistance of the renal collecting duct to the action of the arginine vasopressin hormone responsible for the inability of thekidney to concentrateurine. The X-linked form is due to inactivating mutations of thevasopressin 2 receptor gene leading to a loss of function of the mutated receptors. Conversely, the nephrogenic syndrome of inappropriate antidiuresis (NSIAD) is linked to a constitutive activation of the V(2)-receptor due to activatingmutations with clinical and biological features of inappropriate antidiuresis but with low or undetectable plasma arginine vasopressin hormone levels.
Causes
SIADH is caused by excess of renal water reabsorption through inappropriate antidiuretic hormone secretion, there are various causes attributed to SIADH ranging frommalignancies, drugs, central nervous system causes, infectious. Some of the most common causes are : malignancies like small cell lung cancer, drugs like selective serotonin reuptake inhibitors, and carbamazapine.
Differential diagnosis
SIADH consists ofhyponatremia, inappropriately elevated urineosmolality, excessive urine sodium and decreased serumosmolality in a euvolemic patient without edema. These findings should occur in the absence of diuretic treatment with normalcardiac, renal, adrenal, hepatic and thyroid function.Hyponatremia occurs in about 30% of hospitalized patients and SIADH is the most frequent cause of hyponatremia. Differentiating hyponatremia due to SIADH from other causes of hyponatremia becomes essential to evaluate the treatment plan.
Epidemiology and Demographics
SIADH can occur at any age. It's incidence depends on various possible etiologies. Hyponatremia is the most common electrolyte abnormality in hospitalized patients. Prevalence ofhyponatremia in hospitalized patients from multiple studies came to be about 2.5%-30%.SIADH was the most common clinical setting in hospitalized patients with hyponatremia. The incidence andprevalence of SIADH in particular is less thoroughly studied in the literature.
Risk Factors
The most common causes of SIADH aremalignancy, pulmonary disorders, CNS disorders andmedications.
Screening
There are no screening guidelines for SIADH
Natural History, Complications, and Prognosis
Natural History
The symptoms of SIADH can occur at any age. If untreated can lead tocomplications such as confusion,seizures, stupor and coma.
Complications
Some of the complications of treatment of SIADH are,cerebraledema,central pontine myelinolysis (if sodium level is corrected too rapidly)
Prognosis
The prognosis of Syndrome of inappropriate antidiuretic hormone (SIADH) depends largely on its cause. If the cause is drugs, SIADH usually improves after stopping a drug. If SIADH is associated with some infection, treating the infection may be important. For those SIADH with cancers, the outcomes may be poor.Patients with SIADH have different characteristics and a different prognosis according to SIADH etiology. Serum sodium concentration at short-term follow-up is predictive of long-term survival. These findings might have diagnostic and treatmentrelated implications.
Diagnosis
History and Symptoms
The main problem in patients with SIADH is excess ofwater retention and low sodium levels. Symptoms depend on the levels of sodium in the blood and the rate at which the level of sodium falls. Symptoms may be non-specific like generalised fatigue, weakness,but if severe symptoms such as irritability,nausea, vomiting,muscle weakness and cramps,loss of appetite, confusion,personality changes,hallucinations,seizures,stupor and coma.
Physical Examination
The physical examination findings of SIADH depend on the level of sodium and rate of change of sodium levels.The following are the physical examination findings : Mild-moderate:Headache,lethargy,impaired memory,gait instability,falls.If severe symptoms like confusion,hallucinations,dysarthria,psychosis,seizures,hemiplegia, limb weakness,tremor,and coma may ensue.
Laboratory Findings
Lab findings helpful in diagnosing SIADH, include serum electrolytes,especiallysodium,BUN,creatinine, glucose levels, and osmolality. Patients withsyndrome of inappropriate antidiuretic hormone may be characterised with hyponatremia (sodium <135 mEq/L) and low serum osmolality (<280 mOsm/kg). Patients with syndrome of inappropriate antidiuretic hormone show elevated urinary sodium level (>20 mmol/L) and urine osmolality (generally >100 mOsm/L). They also have low BUN, normal creatinine,low uric acid and low albumin.
Imaging Findings
Imaging Studies, such as x-ray, CT and MRI may be help find thecauses of syndrome of inappropriate antidiuretic hormone.
Other Diagnostic Studies
There are no additional diagnostic findings for SIADH
Treatment
Medical Therapy
Treatment of syndrome of inappropriate antidiuretic hormone depends on the etiology. For immediate improvement, all patients with SIADH require sharp restriction of their dailywater intake and depending on the sodium levels, 3%hypertonic saline,loop diuretics with normal saline may be used. In emergency settings,Vasopressin-2 receptor antagonists (aquaretics, such as conivaptan ortolvaptan) are used. The most definitive way to treat SIADH is to deal with the underlying problem itself.Sometimesurea,demeclocycline and lithium are also used in the treatment of SIADH.
Surgery
If SIADH resulted from cancers; surgery, radiation therapy, or chemotherapy may be helpful.
Prevention
Primary prevention
SIADH to some extent can be avoided by regular review and monitoring of drugs by the health care provider. Otherwise, there are no specific preventive modalities for SIADH.
Secondary prevention
There are no secondary preventive measures available for Cushing's syndrome.